Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group. [electronic resource]
Producer: 19970821Description: 865-72 p. digitalISSN:- 0003-9950
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Choroid -- blood supply
- Choroid Diseases -- diagnosis
- Disease Progression
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Macular Degeneration -- complications
- Male
- Middle Aged
- Neovascularization, Pathologic -- diagnosis
- Recombinant Proteins
- Safety
- Treatment Outcome
- Visual Acuity
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.